Fundraising Fox

Phase Genomics

Seattle, US · Founded 2015 · Delaware corporation · 14 employees on LinkedIn · 4 known investors

Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.

Founders & leadership

Phase Genomics was founded in 2015 by Ivan Liachko and Shawn Sullivan.

ILIvan Liachko
Ivan LiachkoCo-founder
SSShawn Sullivan
Shawn SullivanCo-founder

Investors · 4

Funding

SEC filings, press & company announcements

$7.3M disclosed across 3 rounds · 2017–2024

$4.8MraisedMar 2023 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shawn SullivanExecutive Officer, Promoter
  • Ivan LiachkoExecutive Officer, Director, Promoter
  • Kayla YoungExecutive Officer
Offering amount
$6.6M
Amount sold
$4.8M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1MraisedNov 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivan LiachkoExecutive Officer, Director, Promoter
  • Shawn SullivanExecutive Officer, Promoter
Offering amount
$1.4M
Amount sold
$1M
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Companies competing with Phase Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Phase Genomics do?
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
Who founded Phase Genomics?
Phase Genomics was founded by Ivan Liachko, Shawn Sullivan in 2015.
Who are Phase Genomics's investors?
Phase Genomics's investors include Congruent Ventures, Hemi Ventures, Llc, Alliance of Angels, Bill & Melinda Gates Foundation.
How much funding has Phase Genomics raised?
Phase Genomics has disclosed $7.3M raised across 3 rounds.
Where is Phase Genomics headquartered?
Phase Genomics is headquartered in Seattle, US.